Showing results (1261-1270 of 1,289) with videos related to

Sort By:
Pageof 129
Oncotarget|December 5, 2014
PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignanciesMatthias Scheffler, Marc Bos, Masyar Gardizi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2018
Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancerA Kron, C Alidousty, M Scheffler, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2022
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitorsRichard Riedel, Jana Fassunke, Hannah L Tumbrink, et al.
BMJ Open|August 3, 2021
Study protocol for a mixed methods exploratory investigation of aftercare services for gestational diabetes in women to develop a new patient-centred model in Germany: the GestDiNa_basic studyGregory Gordon Greiner, Anja Viehmann, Ute Linnenkamp, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|April 17, 2026
Health research requires the linking of healthcare-related dataWolfgang Hoffmann, Neeltje van den Berg, Jochen Schmitt, et al.
Zeitschrift Fur Rheumatologie|May 4, 2016
[Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"]J Braun, A Krause, M Aringer, et al.
BMJ Neurology Open|January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysisAymeric Lanore, Marion Houot, Aymeric Basset, et al.
Gut|September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancerJohann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Arthritis and Rheumatism|April 16, 2002
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsRicard Cervera, Jean-Charles Piette, Josep Font, et al.
Zeitschrift Fur Rheumatologie|July 4, 2018
[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]C Fiehn, J Holle, C Iking-Konert, et al.
Pageof 129